Managers / Q1 2025 · view latest →
P2 Capital Partners, LLC
CIK 0001406313 · 590 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10022 · (212) 508-5500
Summary
P2 Capital Partners, LLC reported $515M in U.S.-listed holdings across 12 positions for Q1 2025.
The portfolio is heavily concentrated: CBZ alone accounts for 28.2% of reported value.
Compared with Q4 2024, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 95.8% · $493M
- Other · 4.2% · $22M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ZETAZETA GLOBAL HOLDINGS CORP | NEW | +725.0K | 725.0K | +$10M | $10M |
| BLKBBLACKBAUD INC | TRIMMED | −311.9K | 446.3K | −$28M | $28M |
| FULFULLER H B CO | TRIMMED | −55.0K | 284.4K | −$7M | $16M |
| LIVANOVA PLC | ADDED | +42.1K | 552.9K | −$2M | $22M |
| CBZCBIZ INC | ADDED | +108.1K | 1.92M | −$3M | $145M |
| HSICHENRY SCHEIN INC | HELD | −20.5K | 562.8K | −$2M | $39M |
| ACHCACADIA HEALTHCARE COMPANY IN | HELD | −52.1K | 2.14M | −$22M | $65M |
| IASINTEGRAL AD SCIENCE HLDNG CO | HELD | +0 | 4.81M | −$11M | $39M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | CBZCBIZ INChistory → | COM | 28.23% | $145M | 1.92M |
| 2 | JBTJBT MAREL CORPORATIONhistory → | COM | 14.08% | $73M | 593.6K |
| 3 | ACHCACADIA HEALTHCARE COMPANY INhistory → | COM | 12.61% | $65M | 2.14M |
| 4 | TN1TENNANT COhistory → | COM | 8.00% | $41M | 517.1K |
| 5 | IASINTEGRAL AD SCIENCE HLDNG COhistory → | COM | 7.53% | $39M | 4.81M |
| 6 | HSICHENRY SCHEIN INChistory → | COM | 7.48% | $39M | 562.8K |
| 7 | BLKBBLACKBAUD INChistory → | COM | 5.37% | $28M | 446.3K |
| 8 | AVNTAVIENT CORPORATIONhistory → | COM | 5.03% | $26M | 696.9K |
| 9 | LIVANOVA PLC | SHS | 4.22% | $22M | 552.9K |
| 10 | FULFULLER H B COhistory → | COM | 3.10% | $16M | 284.4K |
| 11 | ENOVENOVIS CORPORATIONhistory → | COM | 2.45% | $13M | 330.0K |
| 12 | ZETAZETA GLOBAL HOLDINGS CORPhistory → | CL A | 1.91% | $10M | 725.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $210M | 10 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $390M | 10 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $520M | 13 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $522M | 13 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $515M | 12 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $589M | 11 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $876M | 15 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $912M | 18 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $846M | 15 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $909M | 15 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $764M | 14 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $859M | 15 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $780M | 15 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $756M | 15 | Feb 23, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $810M | 19 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $883M | 21 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.1B | 22 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.3B | 21 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $1.2B | 20 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $1.3B | 19 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $1.5B | 20 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $1.5B | 18 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.3B | 18 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $1.2B | 17 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $836M | 14 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.4B | 16 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.5B | 16 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.3B | 16 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.2B | 17 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $991M | 17 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.